|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.67 USD | +5.57% |
|
+12.66% | -32.86% |
| 06-27 | Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target | MT |
| 06-26 | BTIG Lowers Price Target on Exact Sciences to $70 From $80, Maintains Buy Rating | MT |
Exact Sciences Corp. announced that John A. Fallon, M.D., has joined the company's board of directors. Dr. Fallon brings more than 40 years of experience in health management, reimbursement, primary care and academic medicine to the board.
Most recently, Dr. Fallon served as chief physician executive and senior vice president of Blue Cross Blue Shield of Massachusetts, the leading health plan in that state with 3 million members.
| 1st Jan change | Capi. | |
|---|---|---|
| -32.86% | 9.17B | |
| +25.06% | 4.14B | |
| +15.74% | 2.63B | |
| -26.46% | 1.85B | |
| -7.09% | 1.95B | |
| +40.61% | 1.22B | |
| +54.75% | 969M | |
| -9.17% | 694M | |
| -9.18% | 656M | |
| -19.58% | 235M |
EXACT SCIENCES CORPORATION 
